TLR4 and cardiac hypertrophy: An increase in TLR4 ligands pool accelerates progression of diseases such as hypertension or cardiac hypertrophy (27, 50), as well as common ligands such as HSPs, HMGB1, LPS, heparan sulfate (HS), fibrinogen, among others.